Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment

Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairme...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia : translational research & clinical interventions Vol. 9; no. 4; pp. e12436 - n/a
Main Authors Padulo, Caterina, Sestieri, Carlo, Punzi, Miriam, Picerni, Eleonora, Chiacchiaretta, Piero, Tullo, Maria Giulia, Granzotto, Alberto, Baldassarre, Antonello, Onofrj, Marco, Ferretti, Antonio, Delli Pizzi, Stefano, Sensi, Stefano L.
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.10.2023
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2352-8737
2352-8737
DOI10.1002/trc2.12436

Cover

Loading…
Abstract Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). Methods Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow‐up: 75 who remained stable (s‐HC) and 22 who converted to MCI within 48 months (c‐HC). Anatomical magnetic resonance (MR) images were analyzed using a semi‐automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD‐related pathology, and the whole cortical thickness as a test of spatial specificity. Results Compared with s‐HC individuals, c‐HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro‐structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48‐month follow‐up), suggesting that amygdala changes shape the cognitive progression to MCI. Discussion Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. Highlights Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI). Amygdala's was observed within the basolateral and amygdaloid complexes. Macro‐structural alterations were associated with cognitive decline. No atrophy was found in the hippocampus and cortex.
AbstractList IntroductionAccumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI).MethodsOur sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow-up: 75 who remained stable (s-HC) and 22 who converted to MCI within 48 months (c-HC). Anatomical magnetic resonance (MR) images were analyzed using a semi-automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD-related pathology, and the whole cortical thickness as a test of spatial specificity.ResultsCompared with s-HC individuals, c-HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro-structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48-month follow-up), suggesting that amygdala changes shape the cognitive progression to MCI.DiscussionOur results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD.HighlightsAmygdala's atrophy marks elderly progression to mild cognitive impairment (MCI).Amygdala's was observed within the basolateral and amygdaloid complexes.Macro-structural alterations were associated with cognitive decline.No atrophy was found in the hippocampus and cortex.
Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow-up: 75 who remained stable (s-HC) and 22 who converted to MCI within 48 months (c-HC). Anatomical magnetic resonance (MR) images were analyzed using a semi-automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD-related pathology, and the whole cortical thickness as a test of spatial specificity. Compared with s-HC individuals, c-HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro-structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48-month follow-up), suggesting that amygdala changes shape the cognitive progression to MCI. Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI).Amygdala's was observed within the basolateral and amygdaloid complexes.Macro-structural alterations were associated with cognitive decline.No atrophy was found in the hippocampus and cortex.
Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI).IntroductionAccumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI).Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow-up: 75 who remained stable (s-HC) and 22 who converted to MCI within 48 months (c-HC). Anatomical magnetic resonance (MR) images were analyzed using a semi-automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD-related pathology, and the whole cortical thickness as a test of spatial specificity.MethodsOur sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow-up: 75 who remained stable (s-HC) and 22 who converted to MCI within 48 months (c-HC). Anatomical magnetic resonance (MR) images were analyzed using a semi-automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD-related pathology, and the whole cortical thickness as a test of spatial specificity.Compared with s-HC individuals, c-HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro-structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48-month follow-up), suggesting that amygdala changes shape the cognitive progression to MCI.ResultsCompared with s-HC individuals, c-HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro-structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48-month follow-up), suggesting that amygdala changes shape the cognitive progression to MCI.Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD.DiscussionOur results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD.Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI).Amygdala's was observed within the basolateral and amygdaloid complexes.Macro-structural alterations were associated with cognitive decline.No atrophy was found in the hippocampus and cortex.HighlightsAmygdala's atrophy marks elderly progression to mild cognitive impairment (MCI).Amygdala's was observed within the basolateral and amygdaloid complexes.Macro-structural alterations were associated with cognitive decline.No atrophy was found in the hippocampus and cortex.
Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). Methods Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow‐up: 75 who remained stable (s‐HC) and 22 who converted to MCI within 48 months (c‐HC). Anatomical magnetic resonance (MR) images were analyzed using a semi‐automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD‐related pathology, and the whole cortical thickness as a test of spatial specificity. Results Compared with s‐HC individuals, c‐HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro‐structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48‐month follow‐up), suggesting that amygdala changes shape the cognitive progression to MCI. Discussion Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. Highlights Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI). Amygdala's was observed within the basolateral and amygdaloid complexes. Macro‐structural alterations were associated with cognitive decline. No atrophy was found in the hippocampus and cortex.
Abstract Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). Methods Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow‐up: 75 who remained stable (s‐HC) and 22 who converted to MCI within 48 months (c‐HC). Anatomical magnetic resonance (MR) images were analyzed using a semi‐automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD‐related pathology, and the whole cortical thickness as a test of spatial specificity. Results Compared with s‐HC individuals, c‐HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro‐structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48‐month follow‐up), suggesting that amygdala changes shape the cognitive progression to MCI. Discussion Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. Highlights Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI). Amygdala's was observed within the basolateral and amygdaloid complexes. Macro‐structural alterations were associated with cognitive decline. No atrophy was found in the hippocampus and cortex.
Author Baldassarre, Antonello
Padulo, Caterina
Onofrj, Marco
Granzotto, Alberto
Ferretti, Antonio
Sestieri, Carlo
Sensi, Stefano L.
Delli Pizzi, Stefano
Chiacchiaretta, Piero
Tullo, Maria Giulia
Punzi, Miriam
Picerni, Eleonora
AuthorAffiliation 5 Department of Innovative Technologies in Medicine and Dentistry “G. d'Annunzio” University of Chieti‐Pescara, Chieti Chieti Italy
4 Molecular Neurology Unit Center for Advanced Studies and Technology (CAST) University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
1 Department of Neuroscience, Imaging, and Clinical Sciences University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
3 Institute for Advanced Biomedical Technologies (ITAB) “G. d'Annunzio” University, Chieti‐Pescara Chieti Italy
2 Department of Humanities University of Naples Federico II Naples Italy
6 Advanced Computing Core Center for Advanced Studies and Technology (CAST) University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
AuthorAffiliation_xml – name: 6 Advanced Computing Core Center for Advanced Studies and Technology (CAST) University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
– name: 2 Department of Humanities University of Naples Federico II Naples Italy
– name: 5 Department of Innovative Technologies in Medicine and Dentistry “G. d'Annunzio” University of Chieti‐Pescara, Chieti Chieti Italy
– name: 4 Molecular Neurology Unit Center for Advanced Studies and Technology (CAST) University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
– name: 1 Department of Neuroscience, Imaging, and Clinical Sciences University “G. d'Annunzio” of Chieti‐Pescara Chieti Italy
– name: 3 Institute for Advanced Biomedical Technologies (ITAB) “G. d'Annunzio” University, Chieti‐Pescara Chieti Italy
Author_xml – sequence: 1
  givenname: Caterina
  surname: Padulo
  fullname: Padulo, Caterina
  organization: University of Naples Federico II
– sequence: 2
  givenname: Carlo
  surname: Sestieri
  fullname: Sestieri, Carlo
  organization: “G. d'Annunzio” University, Chieti‐Pescara
– sequence: 3
  givenname: Miriam
  surname: Punzi
  fullname: Punzi, Miriam
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 4
  givenname: Eleonora
  surname: Picerni
  fullname: Picerni, Eleonora
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 5
  givenname: Piero
  surname: Chiacchiaretta
  fullname: Chiacchiaretta, Piero
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 6
  givenname: Maria Giulia
  surname: Tullo
  fullname: Tullo, Maria Giulia
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 7
  givenname: Alberto
  surname: Granzotto
  fullname: Granzotto, Alberto
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 8
  givenname: Antonello
  surname: Baldassarre
  fullname: Baldassarre, Antonello
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 9
  givenname: Marco
  surname: Onofrj
  fullname: Onofrj, Marco
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 10
  givenname: Antonio
  surname: Ferretti
  fullname: Ferretti, Antonio
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 11
  givenname: Stefano
  orcidid: 0000-0003-4075-0132
  surname: Delli Pizzi
  fullname: Delli Pizzi, Stefano
  email: stefano.dellipizzi@unich.it
  organization: University “G. d'Annunzio” of Chieti‐Pescara
– sequence: 12
  givenname: Stefano L.
  surname: Sensi
  fullname: Sensi, Stefano L.
  email: stefano.sensi@unich.it
  organization: University “G. d'Annunzio” of Chieti‐Pescara
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38053753$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhk1JadI0l_6AYuilFDbVhyXbpxKWfgQChZJeehFjaeRosaWtZG_Zf19tnIYklIJA0uiZl3c087I48sFjUbym5JwSwj5MUbNzyiounxUnjAu2ampeHz04HxdnKW0IIVSwpuXiRXHMGyJ4LfhJ8fNiimF7sy-DLdMWtbNOlzDuewMDlGnurMPBpNL5w2WDekqlDn6HcXK-L6dQjm4wOdR7N7kdlm7cgosj-ulV8dzCkPDsbj8tfnz-dL3-urr69uVyfXG10oIKuZI1IjVQ685w3gLUpqLIgFLZMsNphw3otkMjGtowaRhUCFJqWlHZCWMMPy0uF10TYKO20Y0Q9yqAU7eBEHsF2a0eUIHtoJI1q62kVcvzstxqaKCWQC2ps9bHRWs7dyMancuIMDwSffzi3Y3qw05RItuK8yYrvLtTiOHXjGlSo0sahwE8hjmp3IKmFVISltG3T9BNmKPPf6VYS2S2QyqRqTcPLd17-dvDDLxfAB1DShHtPUKJOsyIOsyIup2RDJMnsHYTTC4cynHDv1PokvLbDbj_j7i6_r5mS84faijO4A
CitedBy_id crossref_primary_10_1016_j_neuroimage_2024_120663
crossref_primary_10_3390_medicina61010130
crossref_primary_10_31083_JIN25991
crossref_primary_10_34133_research_0354
crossref_primary_10_1007_s40120_025_00716_y
crossref_primary_10_31083_j_jin2312220
Cites_doi 10.1016/j.neurobiolaging.2019.07.005
10.1002/alz.046762
10.1002/hbm.23289
10.2174/1567205017666201203085524
10.1212/WNL.0000000000005303
10.1212/01.wnl.0000336925.79704.9f
10.1177/0891988719882102
10.1002/path.2565
10.1002/ana.20100
10.1038/s41467-020-15701-2
10.1097/NEN.0b013e31816a1df3
10.1093/brain/awy132
10.1016/0306-4522(90)90408-V
10.1212/WNL.0b013e31820d62d9
10.1016/j.cub.2007.08.005
10.1016/00223956(82)900334
10.1093/brain/aww243
10.1097/00002093-199700112-00003
10.1016/j.neurobiolaging.2014.06.032
10.1002/hbm.25216
10.1176/ajp.156.2.216
10.1016/j.pscychresns.2011.06.014
10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z
10.1016/j.jalz.2016.11.006
10.1093/geronj/37.3.323
10.1016/j.neuroimage.2013.05.007
10.1002/jmri.26037
10.3233/JAD-220228
10.1017/S1366728911000332
10.1016/j.neuroimage.2017.04.046
10.2174/1567205011666140131123653
10.1111/bpa.12289
10.1016/j.nicl.2023.103374
10.1002/cne.23415
10.1016/j.nlm.2014.02.005
10.1093/jnen/nlx099
10.1016/j.neulet.2022.136958
10.1016/j.neuroimage.2008.12.033
10.1002/gps.3992
10.3389/fnagi.2017.00050
10.1016/j.nicl.2016.12.011
10.1007/s11682-020-00366-8
10.1016/j.pscychresns.2006.01.007
10.1038/nrneurol.2015.250
10.1093/brain/awv236
10.1016/j.neurobiolaging.2018.10.004
10.1212/WNL.0000000000001171
ContentType Journal Article
Copyright 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor for the Alzheimer's Disease Neuroimaging Iniziative
Alzheimer's Disease Neuroimaging Iniziative
CorporateAuthor_xml – name: for the Alzheimer's Disease Neuroimaging Iniziative
– name: Alzheimer's Disease Neuroimaging Iniziative
DBID 24P
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/trc2.12436
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate PADULO et al
EISSN 2352-8737
EndPage n/a
ExternalDocumentID oai_doaj_org_article_afba46727f61493493f3fca8a76a1f07
PMC10694338
38053753
10_1002_trc2_12436
TRC212436
Genre article
Journal Article
GrantInformation_xml – fundername: Exploration to Evaluate Novel Alzheimer's Queries
  funderid: GEENA‐Q‐19‐596282
– fundername: National Institutes of Health
  funderid: U01 AG024904
– fundername: Translational Research Funding for Alzheimer's Disease
  funderid: 18PTC‐19‐602325
– fundername: the Alzheimer's Association
– fundername: the Italian Ministry of Health, the AIRAlzh Onlus
– fundername: Department of Defense
  funderid: W81XWH‐12‐2‐0012
– fundername: Search of Excellence
– fundername: NIA NIH HHS
  grantid: U01 AG024904
– fundername: Translational Research Funding for Alzheimer's Disease
  grantid: 18PTC‐19‐602325
– fundername: ;
  grantid: U01 AG024904
– fundername: Exploration to Evaluate Novel Alzheimer's Queries
  grantid: GEENA‐Q‐19‐596282
– fundername: ;
  grantid: W81XWH‐12‐2‐0012
GroupedDBID 0R~
0SF
1OC
24P
457
53G
6I.
7RV
7X7
8FI
8FJ
AACTN
AAEDW
AAFTH
AAHHS
AALRI
AAXUO
ABMAC
ABUWG
ACCFJ
ACCMX
ACGFS
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEQDE
AEVXI
AEXQZ
AFKRA
AFTJW
AGHFR
AITUG
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMRAJ
AOIJS
AVUZU
BENPR
CCPQU
EBS
EJD
EMOBN
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
M~E
NAPCQ
NCXOZ
O9-
OK1
OVD
OVEED
PIMPY
ROL
RPM
SSZ
TEORI
UKHRP
WIN
AAYWO
AAYXX
CITATION
PHGZM
PHGZT
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5156-67ee1da7cbd339aa7d41e2a11692d31be8ac9bed581826d2a4ea66c1416b5ddd3
IEDL.DBID 24P
ISSN 2352-8737
IngestDate Wed Aug 27 01:09:54 EDT 2025
Thu Aug 21 18:36:01 EDT 2025
Thu Sep 04 22:50:26 EDT 2025
Sun Jul 27 14:02:12 EDT 2025
Wed Feb 19 02:05:39 EST 2025
Tue Jul 01 04:07:38 EDT 2025
Thu Apr 24 23:15:51 EDT 2025
Wed Jan 22 16:17:22 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords magnetic resonance imaging (MRI)
mild cognitive impairment (MCI)
Alzheimer's disease (AD)
amygdala
preclinical
subfields
Language English
License Attribution-NonCommercial
2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5156-67ee1da7cbd339aa7d41e2a11692d31be8ac9bed581826d2a4ea66c1416b5ddd3
Notes Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at
http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
ORCID 0000-0003-4075-0132
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Ftrc2.12436
PMID 38053753
PQID 2906073045
PQPubID 5066177
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_afba46727f61493493f3fca8a76a1f07
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10694338
proquest_miscellaneous_2898956602
proquest_journals_2906073045
pubmed_primary_38053753
crossref_primary_10_1002_trc2_12436
crossref_citationtrail_10_1002_trc2_12436
wiley_primary_10_1002_trc2_12436_TRC212436
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October‐December 2023
PublicationDateYYYYMMDD 2023-10-01
PublicationDate_xml – month: 10
  year: 2023
  text: October‐December 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Alzheimer's & dementia : translational research & clinical interventions
PublicationTitleAlternate Alzheimers Dement (N Y)
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2009; 45
2015; 36
1982; 17
2023; 38
2020; 17
2020; 16
2013; 521
2014; 29
2020; 11
2012; 15
2017; 155
2011; 194
2008; 71
2016; 37
2017; 9
1997; 11
2015; 138
2015; 84
1987
2008; 67
2018; 77
2014; 11
1989
2007; 17
2018; 141
1997; 379
1982; 37
2021; 42
1990; 37
2019; 74
2023; 15
2013; 83
1998
2022; 89
2011; 76
2020; 33
2009; 219
2016; 12
2014; 112
2004; 55
2021; 15
2019; 82
2017; 13
2023; 792
1964
2019; 49
2018; 90
2016; 139
1999; 156
2016; 26
2006; 146
e_1_2_8_28_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
Wechsler D (e_1_2_8_23_1) 1987
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_45_1
Kepp KP (e_1_2_8_3_1) 2023; 15
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
Morris JC (e_1_2_8_24_1) 1989
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_44_1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
Rey A (e_1_2_8_22_1) 1964
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
Spreen O (e_1_2_8_27_1) 1998
e_1_2_8_52_1
e_1_2_8_50_1
References_xml – volume: 37
  start-page: 323
  issue: 3
  year: 1982
  end-page: 329
  article-title: Measurement of functional activities in older adults in the community
  publication-title: J Gerontol
– volume: 67
  start-page: 309
  year: 2008
  end-page: 318
  article-title: Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer's disease
  publication-title: J Neuropathol Exp Neurol
– volume: 84
  start-page: 313
  issue: 3
  year: 2015
  end-page: 324
  article-title: The amygdala: functional organization and involvement in neurologic disorders
  publication-title: Neurology
– volume: 76
  start-page: 727
  issue: 8
  year: 2011
  end-page: 733
  article-title: Local amygdala structural differences with 3T MRI in patients with Alzheimer's disease
  publication-title: Neurology
– volume: 15
  year: 2023
  article-title: The amyloid cascade hypothesis: an updated critical review
  publication-title: Brain
– volume: 90
  start-page: 695
  issue: 15
  year: 2018
  end-page: 703
  article-title: Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies
  publication-title: Neurology
– volume: 379
  start-page: 482
  year: 1997
  end-page: 494
  article-title: Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer disease
  publication-title: J Comp Neurol
– volume: 13
  start-page: 783
  issue: 7
  year: 2017
  end-page: 791
  article-title: Sleep changes without medial temporal lobe or brain cortical changes in community‐dwelling individuals with subjective cognitive decline
  publication-title: Alzheimers Dement
– volume: 71
  start-page: 1986
  issue: 24
  year: 2008
  end-page: 1992
  article-title: Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease
  publication-title: Neurology
– volume: 13
  start-page: 415
  year: 2017
  end-page: 427
  article-title: Alzheimer's Disease Neuroimaging Initiative. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease
  publication-title: NeuroImage Clin
– volume: 11
  start-page: 239
  issue: 3
  year: 2014
  end-page: 252
  article-title: Amygdalar atrophy in early Alzheimer's disease
  publication-title: Curr Alzheimer Res
– volume: 146
  start-page: 251
  issue: 3
  year: 2006
  end-page: 261
  article-title: Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease
  publication-title: Psychiatry Res Neuroimaging
– volume: 26
  start-page: 371
  issue: 3
  year: 2016
  end-page: 386
  article-title: Precortical phase of Alzheimer's disease (AD)‐related tau cytoskeletal pathology
  publication-title: Brain Pathol
– volume: 139
  start-page: 3253
  issue: 12
  year: 2016
  end-page: 3266
  article-title: Alzheimer's Disease Neuroimaging Initiative. Whole‐brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala
  publication-title: Brain
– volume: 74
  start-page: 21
  year: 2019
  end-page: 37
  article-title: Alzheimer's Disease Neuroimaging Initiative. Functional signature of conversion of patients with mild cognitive impairment
  publication-title: Neurobiol Aging
– year: 1998
– volume: 12
  start-page: 131
  issue: 3
  year: 2016
  end-page: 132
  article-title: The rising global tide of cognitive impairment
  publication-title: Nat Rev Neurol
– volume: 89
  start-page: 233
  issue: 1
  year: 2022
  end-page: 245
  article-title: The neuroanatomic correlates of olfactory identification impairment in healthy older adults and in persons with mild cognitive impairment
  publication-title: J Alzheimer's Dis
– volume: 521
  start-page: 4124
  year: 2013
  end-page: 4144
  article-title: Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
  publication-title: J Comp Neurol
– volume: 15
  start-page: 1728
  issue: 4
  year: 2021
  end-page: 1738
  article-title: Alzheimer's Disease Neuroimaging Initiative. Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical markers
  publication-title: Brain Imaging Behav
– volume: 49
  start-page: 152
  issue: 1
  year: 2019
  end-page: 163
  article-title: Age‐related changes in cortical and subcortical structures of healthy adult brains: A surface‐based morphometry study
  publication-title: J Magn Reson Imaging
– volume: 33
  start-page: 7384
  issue: 2
  year: 2020
  article-title: The Neuropsychiatric Inventory: Development and Applications
  publication-title: J Geriatr Psychiatry Neurol
– volume: 36
  start-page: S3
  year: 2015
  end-page: S10
  article-title: Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort
  publication-title: Neurobiol Aging
– volume: 29
  start-page: 127
  year: 2014
  end-page: 136
  article-title: Multiple clock drawing scoring systems: simpler is better
  publication-title: Int J Geriatr Psychiatry
– volume: 194
  start-page: 7
  issue: 1
  year: 2011
  end-page: 13
  article-title: Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
  publication-title: Psychiatry Res Neuroimaging
– volume: 17
  start-page: R868
  issue: 20
  year: 2007
  end-page: R874
  article-title: The amygdala
  publication-title: Curr Biol
– volume: 42
  start-page: 192
  issue: 1
  year: 2021
  end-page: 203
  article-title: Prediction of 7‐year conversion from subjective cognitive decline to mild cognitive impairment
  publication-title: Hum Brain Mapp
– volume: 82
  start-page: 110
  year: 2019
  end-page: 119
  article-title: Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults
  publication-title: Neurobiol Aging
– volume: 17
  start-page: 790
  issue: 9
  year: 2020
  end-page: 804
  article-title: Acting before: a combined strategy to counteract the onset and progression of dementia
  publication-title: Curr Alzheimer Res
– volume: 141
  start-page: 1917
  issue: 7
  year: 2018
  end-page: 1933
  article-title: The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
  publication-title: Brain
– volume: 15
  start-page: 594
  issue: 3
  year: 2012
  end-page: 615
  article-title: Self‐ratings of spoken language dominance: a multilingual naming test (MINT) and preliminary norms for young and aging Spanish‐English bilinguals
  publication-title: Biling Lang Cogn
– volume: 55
  start-page: 815
  year: 2004
  end-page: 828
  article-title: Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
  publication-title: Ann Neurol
– year: 1964
– volume: 219
  start-page: 41
  year: 2009
  end-page: 51
  article-title: Morphological alterations to neurons of the amygdala and impaired fear conditioning in a transgenic mouse model of Alzheimer's disease
  publication-title: J Pathol
– volume: 155
  start-page: 370
  year: 2017
  end-page: 382
  article-title: High‐resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas
  publication-title: NeuroImage
– year: 1987
– volume: 11
  start-page: S13
  year: 1997
  end-page: S21
  article-title: Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study
  publication-title: Alzheimer Dis Assoc Disord.
– start-page: 39
  year: 1989
  article-title: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
  publication-title: Neurology
– volume: 45
  start-page: 855
  year: 2009
  end-page: 866
  article-title: A comparison of automated segmentation and m anual tracing for quantifying hippocampal and amygdala volumes
  publication-title: Neuroimage
– volume: 16
  year: 2020
  article-title: Amygdala tau in preclinical Alzheimer's disease: neuroimaging/normal brain aging
  publication-title: Alzheimers Dement
– volume: 9
  start-page: 50
  year: 2017
  article-title: Hippocampal and amygdala gray matter loss in elderly controls with subtle cognitive decline
  publication-title: Front Aging Neurosci
– volume: 11
  start-page: 2612
  year: 2020
  article-title: Alzheimer's Disease Neuroimaging Initiative; Swedish BioFinder Study. Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
  publication-title: Nat Commun
– volume: 83
  start-page: 472
  year: 2013
  end-page: 484
  article-title: Brain morphometry reproducibility in multicenter 3 T MRI studies: a comparison of cross‐sectional and longitudinal segmentations
  publication-title: NeuroImage
– volume: 138
  start-page: 2814
  year: 2015
  end-page: 2833
  article-title: The preclinical phase of the pathological process underlying sporadic Alzheimer's disease
  publication-title: Brain
– volume: 17
  start-page: 3749
  issue: 1
  year: 1982
  article-title: Development and validation of a geriatric depression screening scale: a preliminary report
  publication-title: J Psychiatr Res
– volume: 38
  year: 2023
  article-title: Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease
  publication-title: NeuroImage Clin
– volume: 37
  start-page: 3979
  issue: 11
  year: 2016
  end-page: 3998
  article-title: In vivo delineation of subdivisions of the human amygdaloid complex in a high‐resolution group template
  publication-title: Hum Brain Mapp
– volume: 156
  start-page: 216
  issue: 2
  year: 1999
  end-page: 222
  article-title: Amygdalar volume and emotional memory in Alzheimer's disease
  publication-title: Am J Psychiatry
– volume: 792
  year: 2023
  article-title: The D‐serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease
  publication-title: Neurosci. Lett.
– volume: 77
  start-page: 2
  issue: 1
  year: 2018
  end-page: 20
  article-title: The amygdala as a locus of pathologic misfolding in neurodegenerative diseases
  publication-title: J Neuropathol Exp Neurol
– volume: 112
  start-page: 2
  year: 2014
  end-page: 16
  article-title: How the amygdala affects emotional memory by altering brain network properties
  publication-title: Neurobiol Learn Mem
– volume: 37
  start-page: 377
  issue: 2
  year: 1990
  end-page: 385
  article-title: Pathological alterations in the amygdala in Alzheimer's disease
  publication-title: Neuroscience
– ident: e_1_2_8_10_1
  doi: 10.1016/j.neurobiolaging.2019.07.005
– ident: e_1_2_8_16_1
  doi: 10.1002/alz.046762
– volume-title: Wechsler Memory Scale Revised: Manual
  year: 1987
  ident: e_1_2_8_23_1
– ident: e_1_2_8_40_1
  doi: 10.1002/hbm.23289
– ident: e_1_2_8_5_1
  doi: 10.2174/1567205017666201203085524
– ident: e_1_2_8_4_1
  doi: 10.1212/WNL.0000000000005303
– ident: e_1_2_8_8_1
  doi: 10.1212/01.wnl.0000336925.79704.9f
– ident: e_1_2_8_30_1
  doi: 10.1177/0891988719882102
– ident: e_1_2_8_36_1
  doi: 10.1002/path.2565
– ident: e_1_2_8_44_1
  doi: 10.1002/ana.20100
– volume-title: L'examen clinique en psychologie
  year: 1964
  ident: e_1_2_8_22_1
– ident: e_1_2_8_32_1
  doi: 10.1038/s41467-020-15701-2
– ident: e_1_2_8_45_1
  doi: 10.1097/NEN.0b013e31816a1df3
– ident: e_1_2_8_43_1
  doi: 10.1093/brain/awy132
– ident: e_1_2_8_20_1
  doi: 10.1016/0306-4522(90)90408-V
– ident: e_1_2_8_41_1
  doi: 10.1212/WNL.0b013e31820d62d9
– ident: e_1_2_8_15_1
  doi: 10.1016/j.cub.2007.08.005
– ident: e_1_2_8_31_1
  doi: 10.1016/00223956(82)900334
– ident: e_1_2_8_38_1
  doi: 10.1093/brain/aww243
– ident: e_1_2_8_29_1
  doi: 10.1097/00002093-199700112-00003
– ident: e_1_2_8_39_1
  doi: 10.1016/j.neurobiolaging.2014.06.032
– ident: e_1_2_8_17_1
  doi: 10.1002/hbm.25216
– ident: e_1_2_8_35_1
  doi: 10.1176/ajp.156.2.216
– ident: e_1_2_8_33_1
  doi: 10.1016/j.pscychresns.2011.06.014
– ident: e_1_2_8_19_1
  doi: 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z
– ident: e_1_2_8_9_1
  doi: 10.1016/j.jalz.2016.11.006
– ident: e_1_2_8_28_1
  doi: 10.1093/geronj/37.3.323
– ident: e_1_2_8_52_1
  doi: 10.1016/j.neuroimage.2013.05.007
– ident: e_1_2_8_42_1
  doi: 10.1002/jmri.26037
– ident: e_1_2_8_48_1
  doi: 10.3233/JAD-220228
– start-page: 39
  year: 1989
  ident: e_1_2_8_24_1
  article-title: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
  publication-title: Neurology
– ident: e_1_2_8_25_1
  doi: 10.1017/S1366728911000332
– ident: e_1_2_8_21_1
  doi: 10.1016/j.neuroimage.2017.04.046
– ident: e_1_2_8_34_1
  doi: 10.2174/1567205011666140131123653
– ident: e_1_2_8_47_1
  doi: 10.1111/bpa.12289
– ident: e_1_2_8_11_1
  doi: 10.1016/j.nicl.2023.103374
– volume-title: Compendium of Neuropsychological Tests
  year: 1998
  ident: e_1_2_8_27_1
– ident: e_1_2_8_46_1
  doi: 10.1002/cne.23415
– ident: e_1_2_8_51_1
  doi: 10.1016/j.nlm.2014.02.005
– ident: e_1_2_8_12_1
  doi: 10.1093/jnen/nlx099
– ident: e_1_2_8_37_1
  doi: 10.1016/j.neulet.2022.136958
– ident: e_1_2_8_53_1
  doi: 10.1016/j.neuroimage.2008.12.033
– ident: e_1_2_8_26_1
  doi: 10.1002/gps.3992
– ident: e_1_2_8_18_1
  doi: 10.3389/fnagi.2017.00050
– ident: e_1_2_8_50_1
  doi: 10.1016/j.nicl.2016.12.011
– ident: e_1_2_8_7_1
  doi: 10.1007/s11682-020-00366-8
– ident: e_1_2_8_49_1
  doi: 10.1016/j.pscychresns.2006.01.007
– ident: e_1_2_8_2_1
  doi: 10.1038/nrneurol.2015.250
– ident: e_1_2_8_13_1
  doi: 10.1093/brain/awv236
– ident: e_1_2_8_6_1
  doi: 10.1016/j.neurobiolaging.2018.10.004
– ident: e_1_2_8_14_1
  doi: 10.1212/WNL.0000000000001171
– volume: 15
  year: 2023
  ident: e_1_2_8_3_1
  article-title: The amyloid cascade hypothesis: an updated critical review
  publication-title: Brain
SSID ssj0001528935
Score 2.3383355
Snippet Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether...
Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy...
IntroductionAccumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether...
Abstract Introduction Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e12436
SubjectTerms Alzheimer's disease
Alzheimer's disease (AD)
Amygdala
Cognition & reasoning
Dementia
Magnetic resonance imaging
magnetic resonance imaging (MRI)
mild cognitive impairment (MCI)
Pathology
preclinical
subfields
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiFegICO4gBS68SNxjqWiqjhwQK1UcbHGr7LSNql2swf-PTNOGnZFBRekHJJ4pNjjcfyNPfOZsXfBtBTuV5e1TKpEf0OWbdSm9IsoEOGD0SGzfX6tzy7Ul0t9uXPUF8WEjfTAo-KOIDlQtF2YcCJpJV5JJg8GmhqqNOaR48d2nKkxPxgdCalnPlJxNKy9-IiTWeZi_j0DZaL-u9Dln0GSu-A1zz6nD9mDCTby47G6j9i92D1m34-HdY9q4n3ilDFJUT8crn9eBVgB32xdDk_b8GVHD7TgsuE5ypyYA6740PPr5SrwOYKIU8rkck3rhU_Yxenn85OzcjorofSISFDVTYxVgMa7IGUL0ARVRQFVVbciyMpFA751MWhDDkUQoCLUta8QjzkdQpBP2UHXd_E54zUs0sIbHRFZqdSASxKMap2HALUysmDvb_Vn_UQkTudZrOxIgSws6dpmXRfs7Sx7M9Jn3Cn1ibphliDK6_wCDcFOhmD_ZQgFO7ztRDuNw40lMnv6iSldsDdzMY4g2haBLvZblKETNBHVLkTBno19PtdEGuK70dhms2cNe1XdL-mWPzJLd0UpxVKagn3IhvOX9tvzbyci3734H5p4ye4LhGJjyOEhOxjW2_gKodPgXudR8guzmRf7
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggEK-UFhnBBaTQxM7DOaFSUVUcOKBWWnGxJn4sK22TkmQP_PvOONksK6pKOSSxD_Z4xv48Hn_D2AerKgr3K-JC-izG_YaMK5er2CROIMIHldvA9vmjuLjKvi_yxeRw66ewyu2cGCZq2xrykZ8QLTmpY5Z_ufkTU9YoOl2dUmg8ZI8CdRnqc7kodz6WHLcTIcemQJyBhi_LmaFUnAydEZ9xeQvszLs1KVD334U3_w-b_BfOhvXo_Cl7MgFJfjqO_DP2wDXP2a_ToWtRcLz1nO5QUhwQh-u_Swtr4P2mDgFrPV819EEumJ6HuHPiEljyoeXXq7Xlc0wRp0uUq448iC_Y1fm3y7OLeMqeEBvEKCj80rnUQmlqK2UFUNosdQLStKiElWntFJiqdjZXtMWwAjIHRWFSRGh1bq2VL9lB0zbuNeMFJD4xKneItTJfQu0lqKyqDVgoMiUj9nErP20manHKcLHWIymy0CRrHWQdsfdz3ZuRUOPOWl9pGOYaRIIdfrTdUk82pcHXkNFJskeMUUl8vPQGFJQFpD4pI3a0HUQ9WWavd3oUsXdzMdoUHZRA49oN1qGcmohzExGxV-OYzy2Rihhwcuyz2tOGvabulzSr34G3O6VLxlKqiH0KinNP__XlzzMR3g7v78Qb9lgg7BrDC4_YwdBt3DHCpKF-G2zhFhzWESo
  priority: 102
  providerName: ProQuest
Title Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Ftrc2.12436
https://www.ncbi.nlm.nih.gov/pubmed/38053753
https://www.proquest.com/docview/2906073045
https://www.proquest.com/docview/2898956602
https://pubmed.ncbi.nlm.nih.gov/PMC10694338
https://doaj.org/article/afba46727f61493493f3fca8a76a1f07
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF9q--KLKH5F67GiLwqxye4m2YAvbWkpCqWWFg5fwiS7ex5cE0lyD_73zmxyOQ-LIIQlHxPIzmayv53M_Iax90bnFO6Xhql0KsT1hgxzm-iwiqxAhA86MZ7t8zK9uFVf5sl8j33e5MIM_BCTw40sw3-vycCh7I62pKF9W4lPODvJ9AE7oNxaKtwg1NXWw5LgYsJX2BSIMtDsZTbxk4qj7e07M5In7r8Pbf4dNPknmPWz0flj9miEkfx4GPcnbM_WT9n3475tUG28cZwyKCkKiMPdr4WBFfBuXfpwtY4vazogB0zHfdQ5MQkseN_wu-XK8CmiiFMK5bIl_-Ezdnt-dnN6EY61E8IKEQqqPrM2NpBVpZEyB8iMiq2AOE5zYWRcWg1VXlqTaFpgGAHKQppWMeKzMjHGyOdsv25q-5LxFCIXVTqxiLSUy6B0ErTKywoMpErLgH3Y6K-oRmJxqm-xKgZKZFGQrguv64C9m2R_DnQa90qd0DBMEkSB7U807aIYLaoAV4Ki_8gOEUYucXPSVaAhSyF2URaww80gFqNddgWR29NHTSUBeztdRoui3yRQ22aNMlRRE1FuJAL2Yhjz6UmkJv6bBPusd96GnUfdvVIvf3jW7phSjKXUAfvoX5x_9L-4uT4Vfu_V_wi_Zg8FQrAh1PCQ7fft2r5ByNSXM28Z2GbzbMYOTs4ur65n3v2A7ddv-jefiBZZ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gAXBOIVKGAEHEAKTew8nANCbWm1pWWFqq1UcQkT21lW2iZlH0L9U_xGZpxslhVVb5VyyMOKbM_Y_jye-YaxN0Zl5O6X-IksIx_3G9LPbKx8HViBCB9UbBzb5yDpn0ZfzuKzDfZnGQtDbpXLOdFN1KbWZCPfJlpyUsco_nTxy6esUXS6ukyh0ajFkb38jVu22cfDzyjft0Ic7A_3-n6bVcDXuHZjpVJrQwOpLoyUGUBqotAKCMMkE0aGhVWgs8KaWBH0NgIiC0miQ0QuRWyMkfjfW2wzoojWHtvc3R98O1lZdWLcwLisngKRDU41Mu04UcX2fKrFB1xQHR_0ahV0yQKuQrj_O2r-C6DdCnhwj91toSvfaXTtPtuw1QP2fWc-rVFUvC45RW2S5xGH88uRgQnw2aJwLnIzPq7ogYw-M-483Ym9YMTnNT8fTwzvvJg4hW2Op2SzfMhOb6RnH7FeVVf2CeMJBGWgVWwR3UVlCkUpQUVZocFAEinpsXfL_st1S2ZOOTUmeUPDLHLq69z1tcded2UvGgqPK0vtkhi6EkS77V7U01HejuIcygIiOrsuEdVkEq9SlhoUpAmEZZB6bGspxLydC2b5SnM99qr7jKOYjmagsvUCy1AWT0TWgfDY40bmXU2kIs6dGNus1rRhrarrX6rxT8cUHlJYs5TKY--d4lzT_nx4sifc3dPrG_GS3e4Pvx7nx4eDo2fsjkDQ1zg3brHefLqwzxGkzYsX7cjg7MdND8a_SrdQgQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkBAvaIhbYIAR8ABSaGPn4jwgNDaqjaEJoU2qeMlOfCmVumTrRWh_jV_HOU6aUjHtbVIf2sSqbJ9z7M_25-8w9saonOh-aZhKF4e43pBhbhMV6r4ViPBBJcarfR6l-yfx12Ey3GB_lndhiFa5HBP9QG1qTXvkPZIlJ3eMk55raRHf9wafzi9CyiBFJ63LdBqNixzay9-4fJt9PNhDW78VYvDleHc_bDMMhBrncaxgZm1kINOlkTIHyEwcWQFRlObCyKi0CnReWpMoguFGQGwhTXWEKKZMjDES__cWu51JRFUYS9kwW-3vJLiU8fk9BWIcHHRk1qmjit58qsUHnFq9MvRqPvRpA67Cuv9TNv-F0n4uHGyxey2I5TuN191nG7Z6wH7uzKc1Go3XjtP9TeIgcTi7HBmYAJ8tSk-Wm_FxRT9o-2fGPeeddAxGfF7zs_HE8I7PxOkC53hKu5cP2cmN9OsjtlnVlX3CeAp919cqsYjzYpdB6SSoOC81GEhjJQP2btl_hW5lzSm7xqRoBJlFQX1d-L4O2Ouu7Hkj5nFlqc9khq4ECXD7B_V0VLTxXIArIaZTbIf4Jpf4cdJpUJClELl-FrDtpRGLdlSYFSsfDtir7jXGMx3SQGXrBZahfJ6IsfsiYI8bm3c1kYrUdxJss1rzhrWqrr-pxr-8ZnhEF5ylVAF77x3nmvYXxz92hf_29PpGvGR3MASLbwdHh8_YXYHor2E5brPN-XRhnyNam5cvfFhwdnrTcfgX_tNTSA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atrophy+of+specific+amygdala+subfields+in+subjects+converting+to+mild+cognitive+impairment&rft.jtitle=Alzheimer%27s+%26+dementia+%3A+translational+research+%26+clinical+interventions&rft.au=Padulo%2C+Caterina&rft.au=Sestieri%2C+Carlo&rft.au=Punzi%2C+Miriam&rft.au=Picerni%2C+Eleonora&rft.date=2023-10-01&rft.issn=2352-8737&rft.eissn=2352-8737&rft.volume=9&rft.issue=4&rft.spage=e12436&rft_id=info:doi/10.1002%2Ftrc2.12436&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-8737&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-8737&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-8737&client=summon